HSD vs EDS - Are We Asking the Right Questions presented by Dr. Saperstein

Dr. Saperstein discusses the ongoing debate over the diagnostic criteria for Hypermobility Spectrum Disorder (HSD) versus Ehlers-Danlos Syndrome (EDS), emphasizing that the distinction may not be as critical as addressing the broader spectrum of symptoms experienced by these patients. He highlights that individuals diagnosed with either condition often present with similar comorbidities, such as POTS, gastrointestinal issues, and Mast Cell Activation Syndrome. He suggests that future diagnostic criteria should consider these associated conditions and familial patterns. Despite the current lack of a genetic marker to differentiate between HSD and EDS definitively, management of both conditions remains similar, focused on treating specific symptoms like joint complications, POTS, and MCAS.